Company news
Compass Therapeutics, Inc. news in 2023
Compass Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 8, 2023
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 2, 2023
Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
June 21, 2023
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
May 3, 2023
Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ
April 25, 2023
Compass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
April 18, 2023
Compass Therapeutics to Participate in the Cantor Fitzgerald Future of Oncology Symposium
March 27, 2023
Compass Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 14, 2023
Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
February 1, 2023
Compass Therapeutics Announces that the Phase 2 Data of CTX-009 in Combination with Paclitaxel in Patients with Biliary Tract Cancers (BTC) will be Presented at the ASCO GI Cancers Symposium on January 20, 2023
January 18, 2023
Compass Therapeutics Announces First Patient Dosed in the Phase 2 U.S. Study of CTX-009 in Patients with Metastatic Colorectal Cancer
January 5, 2023
Decks in 2023
- Technical Presentation (January 2023)
Technical · 20 slides · Jan 23, 2023